T he lymphatic vessels maintain the homeostasis of tissue fluid, function as an immunological surveillance mechanism in the living body, and play an important role in ingesting fat and the fat-soluble vitamins A, D, E, and K. The lymphatic vessels were first identified by an Italian anatomist, Gasparo Aselli, as "milky veins" in the canine mesentery in 1627. Since then, various techniques have been developed to investigate the lymphatic vessels to reveal their distribution and structure. 1) However, it was often difficult to identify lymphatic vessels in a tissue section because no specific marker was available. At the end of the 20th century, lymphatic vessel-specific markers, such as Prox-1, 2) podoplanin, 3) LYVE-1, 4) VEGFR-3, 5) CCL21, 6) and desmoplakin, 7) were discovered. These markers have accelerated investigations on lymphatic vessels, and should advance the diagnoses and treatments of various lymphatic disorders. The lymph node is an important intersection of antigen-presenting cells, antigens carried by the lymphatic vessels, and lymphocytes supplied by the blood. The lymph node consists of a lumen surrounded by lymphatic endothelial cells and parenchyma, featuring a reticular structure filled with lymphocytes, etc. The water of lymph from the afferent lymphatic vessels is absorbed into the lymph node to Department of Anatomy, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Toyama, Japan concentrate proteins. Lymph node metastasis of a tumor is the main negative prognostic factor. However, lymphadenectomy for cancer treatment causes lymphedema. We herein describe the morphology, structure, and functions of lymphatic vessels and lymphangiogenesis.
Morphology of lyMphatIc Vessels
There are two kinds of lymphatic vessel: lymphatic vessels of origin, or lymphatic capillaries and lymphatic aggregates. The lymphatic capillary consists of a layer of lymphatic endothelial cells (LECs). Most lymphatic capillaries have valves at intervals of hundreds of microns to several millimeters to allow one-directional lymphatic flow (Fig. 1) . Unlike blood vessels, the lymphatic capillary features a poorly-developed basal membrane and no pericyte. The lymphatic vessels are bound to the surrounding extracellular matrix through an anchoring filament 8) containing fibrillin. 9) Doubly or triply overlapping adhesive regions and gating non-adhesive micro valves exist between LECs. A pressure rise in the interstitial fluid increases the tension of the anchoring filaments attached to the LECs, thereby dilating the lymphatic capillary. Then, the non-adhesive regions between LECs open to allow liquid, macromolecules, and cells to enter the lymphatic vessels.
The lymphatic aggregates have valves and smooth muscles. Smooth muscles contract to cause lymphatic transport. Smooth muscles tend to run circularly around the valves and obliquely between the valves (Fig. 2) . The smooth muscles in the lymphatic aggregates develop depending on the regions and species.
The human thoracic duct has three layers of well-developed smooth muscles. Smooth muscles run longitudinally in the inner layer and circularly in the middle layer. The smooth muscle bundles run obliquely or spirally in the outer layer. 10) The middle layer is the thickest, and the inner and outer layers are relatively thinner. These layers cause peristaltic movement to allow lymphatic transport against gravity.
lyMphangIogenesIs
In 1902, Sabin (Florence) proposed that primitive lymph sacs are formed through sprouting from the veins in an early developmental stage, from which the endothelium sprouts into the surrounding tissues and organs to form peripheral lymphatic vessels. 11) Oliver (2004) employed genetically-engineered mice to demonstrate Sabin's hypothesis that mammalian lymphatic vessels develop from embryonic veins. 12) VEGF-C promotes the proliferation and migration of cultured LECs through VEGFR-3. 13) Furthermore, VEGF-A, VEGF-C, and VEGF-D promote lymphangiogenesis through VEGF receptor or neuropilin 2. The molecular regulatory mechanisms of lymphangiogenesis have been rapidly elucidated. For details, see a review. 14) Environmental factors that promote LEC proliferation and lymphangiogenesis remain unclear. LECs collected from the rat thoracic duct more rapidly reached confluency when cultured under hypoxic conditions than when cultured under a 5% CO 2 atmosphere. LECs cultured on an insert under hypoxic conditions proliferate in layers to form lymphatic vessels (Fig. 3) . Cells collected from the human thoracic duct and diaphragm were dissolved. Only the collagen fiber network was removed, with its natural three-dimensional structure maintained. 15, 16) LECs cultured on the network under hypoxic conditions rapidly formed lymphatic vessels in three dimensions (Fig. 4) . These findings suggest that a hypoxic environment and three-dimensional scaffold are critical for lymphangiogenesis. 17) Only a few studies have been conducted on the in vivo development of lymphatic vessels. We have investigated lymphatic vessel development in the rat diaphragm. [18] [19] [20] Lymphatic vessels can be clearly recognized in the thoracic region of the diaphragm from embryonic day 16. After a while, they also appear in the peritoneal region. Lymphatic vessels develop mainly through sprouting. However, we previously suggested that LECs discretely migrated to form a line in regions where lymphatic vessels may be formed and the LECs aggregated to form lymphatic vessels (Fig. 5) . 17) Alternatively, the LECs discretely migrate in the direction of interstitial fluid flow and subsequently aggregate to form lymphatic vessels. 21) Little attention has been paid to the development of smooth muscles in lymphatic aggregates. Our study on the rat diaphragm 19) revealed many spindle-shaped cells expressing α-smooth muscle actin (α-SMA) until two weeks after birth. Subsequently, α-SMA-positive cells wrapped with elongated extensions were observed around the lymphatic vessels. After a while, typical smooth muscles circularly or spirally bound to the lymphatic vessels were observed. These findings suggest that the smooth muscles of lymphatic vessels differentiate from mesenchymal cells. 19) Fig. 3 LECs expressing LYVE-1 from the thoracic duct of the green rat (transgenic SD rats containing fluorescent genes; Amersham, Tokyo) cultured on an insert under a low oxygen condition proliferate rapidly and form a lymphatic-like network. Scale bar = 100m Fig. 4 LECs from the rat thoracic duct cultured on a collagen fiber sheet from the human thoracic duct rapidly form a three-dimensional lymphatic network. Scale bar = 25m
structure and functIons of lyMph nodes
The lymph node is an important intersection of antigen-presenting cells, antigens carried by the lymphatic vessels, and lymphocytes supplied by the blood to initiate an immune response. The lymph node consists of a lumen surrounded by lymphatic endothelial cells and parenchyma, featuring a reticular structure filled with lymphocytes, etc. 22) In the parenchyma, the cortex is connected to myelin through the deep cortex. The afferent lymphatic vessels flow into the cortical lymphatic sinuses. Fluid and cells enter the cortex through the pores on the bed of the cortical lymphatic sinuses (Fig. 6) . A lymphatic labyrinth filled with lymphocytes exists in the deep cortex. The lymphatic labyrinth is connected to the medullary sinuses. The medullary sinuses feature a large internal diameter with a well-developed beam column surrounded by LECs and many macrophages entangled. The cortical lymphatic sinuses are also connected to the medullary sinuses through the intermediary sinuses. The intermediary sinuses have the same structure as the medullary sinuses. High endothelial venules (HEVs) develop in the deep cortex. Circulating lymphocytes enter the lymph node parenchyma through the HEV wall (Fig. 7) . On the other hand, lymphocytes from the parenchyma enter the lymphatic labyrinth in the deep cortex (Fig. 7) . CCR7 is expressed in the lymphatic labyrinth.
Lymph from the afferent lymphatic vessels is absorbed into the lymph nodes to concentrate proteins. 23) This mechanism remains unclear. Water may be absorbed from the HEV wall into the blood vessels, because a water channel called Aquaporine-1 is strongly expressed near the surface of the endothelial cells of HEVs. 22) This suggests a functional intravenous shunt of lymphatic vessels in the lymph node.
Lymph node metastasis of a tumor is the main aggravating factor of patient prognosis. Recently, some kinds of human tumor were found to produce VEGF-A, -C, and -D. Such tumors facilitate lymphatic vessel proliferation and promote sentinel lymph node metastasis. 24) VEGF-C expression is correlated with Cox-2 expression in human stomach and colorectal cancers. 25, 26) Reportedly, a Cox-2 inhibitor suppresses lymphangiogenesis when administered to an experimental tumor model. Thus, lymphangiogenesis inhibition in a tumor has been investigated as a cancer therapy strategy. The mechanism of tumor cell metastasis to the lymph node remains unclear. Lewis lung carcinoma (LLC) cells, transplanted in the mouse lung, metastasize to the mediastinal lymph node. 27) GFP-expressing LLC cells were investigated as a model to demonstrate that LLC cells reached and scattered in the cortical lymphatic sinus and proliferated to form a tumor nodule. LLC cells scatter around the nodule and exist independently or form a small cell population. LLC cells that passed through the medullary sinus metastasize to other lymph nodes. Preventing tumor cells from passing through the medullary sinus may also provide an effective cancer therapy strategy.
Well-developed smooth muscles exist in the capsule of the lymph node. Smooth muscles in the capsule of the lymph node are better developed in the axillary or inguinal lymph nodes than in the cervical lymph nodes. Lymphocytes and lymph are squeezed out by the capsular smooth muscles into the efferent vessels. The lymph nodes absorb about half of the water in the lymph into the blood. Lymphadenectomy for cancer treatment often causes lymphedema. Lymphadenectomy abrogates the above two functions of the lymph nodes to cause lymph retention and lymphedema. Lymphatic-venous anastomosis, as well as conservative therapies, such as lymph drainage and donning of an elastic stocking, is effective in treating lymphedema. Autologous lymph node transplantation should be therapeutically effective. 
